Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics.
Bi V, Jawa V, Joubert MK, Kaliyaperumal A, Eakin C, Richmond K, Pan O, Sun J, Hokom M, Goletz TJ, Wypych J, Zhou L, Kerwin BA, Narhi LO, Arora T.
Bi V, et al. Among authors: zhou l.
J Pharm Sci. 2013 Oct;102(10):3545-55. doi: 10.1002/jps.23663. Epub 2013 Aug 7.
J Pharm Sci. 2013.
PMID: 23925953